Get started
NNN

NEXTGEN BIOMED LTD

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

NXGN chart


Full chart

Key stats



About NEXTGEN BIOMED LTD


Sector
Health Technology
CEO
Harel Moshe Hershtik
Headquarters
Raanana
Founded
1990
ISIN
IL0010839301
FIGI
BBG000BJNFW1
Nextgen Biomed Ltd. operates as a research and development company. Its primary product is Eyepen, a smart and modular device consisting of pens for injecting insulin, and helps users self-manage the treatment of diabetes by documenting the times and doses of taking insulin by injection. The company was founded on December 26, 1990 and is headquartered in Raanana, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NXGN is 68.4 ILA — it has increased by 2.55% in the past 24 hours. Watch NEXTGEN BIOMED LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange NEXTGEN BIOMED LTD stocks are traded under the ticker NXGN.
NXGN stock has fallen by −2.29% compared to the previous week, the month change is a −7.32% fall, over the last year NEXTGEN BIOMED LTD has showed a −61.66% decrease.
NXGN reached its all-time high on Apr 26, 2010 with the price of 94,185.5 ILA, and its all-time low was 62.0 ILA and was reached on Oct 9, 2024. View more price dynamics on NXGN chart.
See other stocks reaching their highest and lowest prices.
NXGN stock is 7.95% volatile and has beta coefficient of 0.12. Track NEXTGEN BIOMED LTD stock price on the chart and check out the list of the most volatile stocks — is NEXTGEN BIOMED LTD there?
Today NEXTGEN BIOMED LTD has the market capitalization of ‪6.61 M‬, it has increased by 3.98% over the last week.
Yes, you can track NEXTGEN BIOMED LTD financials in yearly and quarterly reports right on TradingView.
NXGN net income for the last half-year is ‪−1.71 M‬ ILS, while the previous report showed ‪−6.91 M‬ ILS of net income which accounts for 75.24% change. Track more NEXTGEN BIOMED LTD financial stats to get the full picture.
No, NXGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NXGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEXTGEN BIOMED LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NEXTGEN BIOMED LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NEXTGEN BIOMED LTD stock shows the sell signal. See more of NEXTGEN BIOMED LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.